STAT+: Michigan Supreme Court ruling allows probe into Lilly insulin pricing

The Michigan Supreme Court allowed the state's attorney general to investigate Eli Lilly's insulin pricing practices, rejecting a prior court's decision. The probe alleges the company artificially inflated prices for three insulin products, leading to patient hardships including rationing and health risks.